Bespoke Extracts (BSPK) Change in Accured Expenses (2016 - 2025)
Bespoke Extracts' (BSPK) quarterly Change in Accured Expenses came in at $48628.0 in Q3 2025, down 58.65% year-on-year from $117596.0 in Q3 2024, and down 77.96% quarter-over-quarter from $220641.0 in Q2 2025.
Bespoke Extracts (BSPK) Change in Accured Expenses (2016 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Change in Accured Expenses across 10 years of filings, most recently posting $48628.0 for Q3 2025.
- Change in Accured Expenses for Q3 2025 came in at $48628.0, down 58.65% year-over-year; the trailing twelve-month figure through Sep 2025 was $453878.0 (down 26.32% YoY), and the FY2024 annual result was $505019.0, down 24.11% from the prior year.
- Change in Accured Expenses came in at $48628.0 for Q3 2025 at Bespoke Extracts, down from $220641.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $220641.0 in Q2 2025 to a low of -$53792.0 in Q2 2021.
- The 5-year median for Change in Accured Expenses is $94784.5 (2022), against an average of $99891.8.
- Across the five-year window, Change in Accured Expenses sank 413.53% in 2021 and jumped 757.31% in 2023, its largest moves.
- Bespoke Extracts' Change in Accured Expenses stood at $18266.0 in 2021, then jumped by 294.03% to $71973.0 in 2022, then surged by 80.95% to $130237.0 in 2023, then slumped by 85.19% to $19285.0 in 2024, then soared by 152.15% to $48628.0 in 2025.
- The last three Change in Accured Expenses figures came in at $48628.0 (Q3 2025), $220641.0 (Q2 2025), and $165324.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | 48,628.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 48,628.00 |
| Sep 30, 2025 | 48,628.00 |
| Jun 30, 2025 | 220,641.00 |
| Jun 30, 2025 | 220,641.00 |
| Mar 31, 2025 | 165,324.00 |
| Mar 31, 2025 | 165,324.00 |
| Dec 31, 2024 | 19,285.00 |
| Dec 31, 2024 | 19,285.00 |
| Sep 30, 2024 | 117,596.00 |
| Sep 30, 2024 | 117,596.00 |
| Jun 30, 2024 | 192,096.00 |
| Jun 30, 2024 | 192,096.00 |
| Mar 31, 2024 | 176,042.00 |
| Mar 31, 2024 | 176,042.00 |
| Dec 31, 2023 | 130,237.00 |
| Dec 31, 2023 | 130,237.00 |
| Sep 30, 2023 | 215,588.00 |
| Sep 30, 2023 | 215,588.00 |
| Jun 30, 2023 | 123,356.00 |
| Jun 30, 2023 | 123,356.00 |